Research Nester released a report titled “Antidepressant Drugs Market: Global Demand Analysis & Opportunity Outlook 2028” which delivers detailed overview of the global antidepressant drugs market in terms of market segmentation by drug class, by depressive disorder and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Depressive disorders can be of various types – anxiety disorder, panic disorder, obsessive compulsive disorder and major depressive disorder. These negatively impact the mental health and decrease the productivity of the person affected. They can be treated with the help of medications known as antidepressants. The antidepressant drugs market is anticipated to record a CAGR of around 2.5% over the forecast period, i.e., 2020-2028. The market is segmented by drug class, by depressive disorder and by region, out of which, the drug class segment is further segmented into serotonin and noradrenaline reuptake inhibitors [SNRIs], selective serotonin reuptake inhibitors [SSRIs], tricyclic antidepressants [TCAs], monoamine oxidase inhibitors [MAOIs], noradrenaline and specific serotoninergic antidepressants [NASSAs] and others. The segment for selective serotonin reuptake inhibitors [SSRIs] is anticipated to hold the leading share in the antidepressant drugs market on account of large number of drugs belonging to this drug class which are globally available.

Based on region, the antidepressant drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to hold the largest share on account of high demand for antidepressant drugs by the people in the region and growing cases of depressive disorders and other mental health disorders in the region.

Increasing Stress Levels and Unhealthy Lifestyles to Boost the Market Growth

As per the 2018 statistics by Mental Health Foundation, 74% of people in the UK have felt so stressed that they felt overwhelmed or were not able to cope.

The growing levels of stress in today’s time results in various mental health disorders which requires immediate attention. The growing use of antidepressants as a result of these disorders is anticipated to increase the market growth over the forecast period. However, the side effects associated with the antidepressant drugs, including weight gain, nausea, dizziness, dry mouth, headaches and others, is predicted to hamper the market growth.

This report also provides the existing competitive scenario of some of the key players of the global antidepressant drugs market which includes company profiling of Allergan, Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc., Johnson & Johnson Services, Inc., AstraZeneca, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited and Alkermes. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global antidepressant drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.